Hong Kong health care stocks surged in early trading, with Huale Pharmaceutical-B rising over 12%.

Hong Kong-listed pharmaceutical stocks rose in early trading, with Hualei Pharmaceutical-B up over 12%, Shiyao Group up over 7%, and Xinda Biotechnology, BeiGene, and Fosun Pharma all seeing gains.